ଉଇକିପିଡ଼ିଆ

ମୋଡର୍ନା କୋଭିଡ଼-୧୯ ଟିକା

ଏହା ଏକ କୋଭିଡ଼-୧୯ ଟିକା ।

ମୋଡର୍ନା କୋଭିଡ଼-୧୯ ଟିକା (ଇଂରାଜୀ ଭାଷାରେ ModernaCOVID-19 vaccine ), ଜେନେରିକ୍ ନାମ ଏଲାସୋମେରାନ ଏବଂ ବେପାର ନାମ ସ୍ପାଇକେଭାକ୍ସଦ୍ୱାରା ଜଣାଶୁଣା, ଏକ କୋଭିଡ଼-୧୯ ଟିକା ।[୩] [୨୪] କୋଭିଡ-୧୯ ବିରୋଧରେ ସୁରକ୍ଷା ଯୋଗାଇବା ପାଇଁ ସ୍ଥାନ ବିଶେଷରେ ଏହା ଏକାଦଶ କିମ୍ବା ସତର ବର୍ଷରୁ ଅଧିକ ବୟସର ଲୋକଙ୍କଠାରେ ବ୍ୟବହୃତ ହୁଏ ।[୨୫] [୩] [୨୬] ଏହା ପ୍ରାରମ୍ଭରେ ୯୪% ପ୍ରଭାବଶାଳୀ ବୋଲି ଜଣାପଡିଛି ।[୨୬] ଅତି କମରେ ୨୮ଦିନ ବ୍ୟବଧାନରେ ମାଂସପେଶୀରେ ଏହା ଇଂଜେକସନ ଆକାରରେ ଦୁଇ କିମ୍ବା ତିନି ଥର ୦.୫ ମିଲି ମାତ୍ରାରେ ଦିଆଯାଏ | [୨୫]

ମୋଡର୍ନା କୋଭିଡ଼-୧୯ ଟିକା
Vials of the Moderna COVID-19 vaccine
Vaccine description
Target diseaseSARS-CoV-2
Type?
Clinical data
Pronunciation/məˈdɜːrnə/ mə-DUR-nə[୫]
Trade namesSpikevax[୩]
SynonymsmRNA-1273, CX-024414, COVID-19 mRNA vaccine Moderna, TAK-919, COVID-19 vaccine moderna intramuscular injection[୪]
AHFS/Drugs.commonograph
MedlinePlusa621002
data
Pregnancy
category
Routes of
administration		Intramuscular
Legal status
Legal status

ଅଧିକାଂଶ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟା ସାମାନ୍ୟରୁ ମଧ୍ୟମ ହୁଏ ଏବଂ କିଛି ଦିନ ମଧ୍ୟରେ ଉପଶମ ହୋଇଯାଏ ।[୩] ଇଞ୍ଜେକ୍ସନ ନେଇଥିବା ସ୍ଥାନରେ ଯନ୍ତ୍ରଣା, ଥକ୍କା, ଜ୍ୱର, ଲସିକା ଗ୍ରନ୍ଥି ଫୁଲିବା, ମୁଣ୍ଡବିନ୍ଧା ଏବଂ ମାଂସପେଶୀ ଯନ୍ତ୍ରଣା ହୋଇପାରେ ।[୩] ବିରଳ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଆନାଫାଇଲକ୍ସିସ୍, ଫେସିଆଲ୍ ପାଲସି, ପେରିକାର୍ଡ଼ାଇଟିସ ଏବଂ

ମାୟୋକାର୍ଡ଼ାଇଟିସ ହୋଇପାରେ ।[୩] ଗର୍ଭାବସ୍ଥାରେ ବ୍ୟବହାର କଲେ କ୍ଷତିର କୌଣସି ପ୍ରମାଣ ମିଳିନାହିଁ । [୧] ଏହା ଏକ ଏମଆରଏନଏ ଟିକା, ଯେଉଁଥିରେ ନ୍ୟୁକ୍ଲିଓସାଇଡ୍-ରୂପାନ୍ତରିତ ଏମଆରଏନଏ (modRNA) ଯାହା ଏସଏଆରଏସ-ସିଓଭି-୨ର ସ୍ପାଇକ୍ ପ୍ରୋଟିନ୍ ଏନକୋଡିଂକୁ ନେଇ ଗଠିତ, ଯାହା ଲିପିଡ ନାନୋ-ପାର୍ଟିକଲ୍ସରେ ଆବଦ୍ଧ ।[୨୭]

ଏହି ଟିକା ଡିସେମ୍ବର ୨୦୨୦ରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଜରୁରୀକାଳୀନ ବ୍ୟବହାର ପ୍ରାଧିକରଣ (EUA) ଗ୍ରହଣ କରିଥିଲା ଏବଂ ଜାନୁୟାରୀ ୨୦୨୧ରେ ୟୁରୋପରେ ଚିକିତ୍ସା ପାଇଁ ଅନୁମୋଦନ କରାଯାଇଥିଲା ।[୨୫] [୩] ୨୦୨୨ସୁଦ୍ଧା ଅତି କମରେ ୮୬ଟି ଦେଶରେ ଏହା କିଛି ସ୍ତରରେ ବ୍ୟବହାର ପାଇଁ ଅନୁମତିପ୍ରାପ୍ତ ହୋଇଛି ।[୨୮] [୨୯] ୨୦୨୦ରେ ଏହା ସରକାରଙ୍କୁ ପ୍ରାୟ ୩୫ଡଲାରରେ ବିକ୍ରି ହେଉଥିଲା। [୩୦] ଆମେରିକୀୟ କମ୍ପାନୀ ମୋଡର୍ନା, ଯୁକ୍ତରାଷ୍ଟ୍ରର ନ୍ୟାସନାଲ ଇନଷ୍ଟିଚ୍ୟୁଟ୍ ଅଫ୍ ଆଲର୍ଜି ଏବଂ ସଂକ୍ରାମକ ରୋଗ (NIAID) ଏବଂ ବାୟୋମେଟିକାଲ୍ ଆଡଭାନ୍ସଡ ରିସର୍ଚ୍ଚ ଆଣ୍ଡ ଡେଭଲପମେଣ୍ଟ ଅଥରିଟି (BARDA)ଦ୍ୱାରା ଏହା ବିକଶିତ ହୋଇଥିଲା | [୩୧] ଏହା ପ୍ରଥମ କୋଭିଡ଼-୧୯ ଟିକା ଥିଲା ଯାହା ମଣିଷମାନଙ୍କଠାରେ ଅଧ୍ୟୟନ କରାଯାଇଥିଲା ।[୩୨]

ଆଧାର ସମ୍ପାଦନା

  1. ↑ ୧.୦ ୧.୧ "Spikevax". Therapeutic Goods Administration (TGA). 9 August 2021. Archived from the original on 28 August 2021. Retrieved 28 August 2021.
  2. ↑ ୨.୦ ୨.୧ "Spikevax (elasomeran) Covid-19 Vaccine Product Information Licence" (PDF). Therapeutic Goods Administration (TGA). 18 August 2021. Archived from the original on 28 August 2021. Retrieved 28 August 2021.
  3. ↑ ୩.୦ ୩.୧ ୩.୨ ୩.୩ ୩.୪ ୩.୫ ୩.୬ ୩.୭ "Spikevax (previously COVID-19 Vaccine Moderna) EPAR". European Medicines Agency (EMA). 4 January 2021. Archived from the original on 28 June 2021. Retrieved 29 June 2021.
  4. ↑ "Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan" (Press release). Takeda. 21 May 2021. Archived from the original on 23 December 2021. Retrieved 3 January 2022.
  5. ↑ Moderna (23 October 2019). mRNA-3704 and Methylmalonic Acidemia (Video). YouTube. Archived from the original on 28 February 2021. Retrieved 19 January 2021.
  6. ↑ "Summary For Artg Entry: 370599 Spikevax (elasomeran) Covid-19 Vaccine 0.2 Mg/Ml Suspension For Injection Vial" (PDF). Therapeutic Goods Administration (TGA). Retrieved 28 August 2021.{{cite web}}: CS1 maint: url-status (link)
  7. ↑ ଆଧାର ଭୁଲ: ଅଚଳ <ref> ଚିହ୍ନ; TGA provisional approval ନାମରେ ଥିବା ଆଧାର ଭିତରେ କିଛି ଲେଖା ନାହିଁ ।
  8. ↑ ଆଧାର ଭୁଲ: ଅଚଳ <ref> ଚିହ୍ନ; TGA provisional approval 2 ନାମରେ ଥିବା ଆଧାର ଭିତରେ କିଛି ଲେଖା ନାହିଁ ।
  9. ↑ ଆଧାର ଭୁଲ: ଅଚଳ <ref> ଚିହ୍ନ; CA COVID-19 authorizations ନାମରେ ଥିବା ଆଧାର ଭିତରେ କିଛି ଲେଖା ନାହିଁ ।
  10. ↑ ଆଧାର ଭୁଲ: ଅଚଳ <ref> ଚିହ୍ନ; CA Spikevax ନାମରେ ଥିବା ଆଧାର ଭିତରେ କିଛି ଲେଖା ନାହିଁ ।
  11. ↑ "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)". COVID-19 vaccines and treatments portal. 23 December 2020. Archived from the original on 23 December 2020. Retrieved 23 December 2020.
  12. ↑ "Regulatory Decision Summary - COVID-19 Vaccine Moderna". Health Canada. Archived from the original on 27 August 2021. Retrieved 28 August 2021.
  13. ↑ "Archive copy" (PDF). Archived (PDF) from the original on 2021-12-03. Retrieved 2022-01-03.{{cite web}}: CS1 maint: archived copy as title (link)
  14. ↑ "Regulatory Decision Summary - Spikevax". Health Canada. 13 November 2020. Archived from the original on 17 September 2021. Retrieved 18 September 2021.
  15. ↑ ଆଧାର ଭୁଲ: ଅଚଳ <ref> ଚିହ୍ନ; EU approval ନାମରେ ଥିବା ଆଧାର ଭିତରେ କିଛି ଲେଖା ନାହିଁ ।
  16. ↑ "Summary of Product Characteristics for Spikevax". Medicines and Healthcare products Regulatory Agency (MHRA). 20 August 2021. Archived from the original on 18 February 2021. Retrieved 29 August 2021.
  17. ↑ "Regulatory approval of Spikevax (formerly COVID-19 Vaccine Moderna)". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Archived from the original on 18 February 2021. Retrieved 29 August 2021.
  18. ↑ "Regulatory approval of Spikevax (formerly COVID-19 Vaccine Moderna)". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Archived from the original on 28 August 2021. Retrieved 29 August 2021.
  19. ↑ "Summary of the Public Assessment Report for Spikevax". Medicines and Healthcare products Regulatory Agency (MHRA). 19 February 2021. Archived from the original on 22 April 2021. Retrieved 29 August 2021.
  20. ↑ "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). Archived from the original on 17 March 2021. Retrieved 18 December 2020.
  21. ↑ "Moderna COVID-19 Vaccine – cx-024414 injection, suspension". DailyMed. Archived from the original on 4 April 2021. Retrieved 20 December 2020.
  22. ↑ (PDF) Moderna COVID-19 Vaccine Emergency Use Authorization (Report). 12 August 2021. https://www.fda.gov/media/144636/download. Retrieved 13 August 2021.    This article incorporates text from this source, which is in the public domain.
  23. ↑ "Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). Centers for Disease Control and Prevention (CDC). 16 July 2021. Archived (PDF) from the original on 14 August 2021.
  24. ↑ "TGA grants provisional determination for the Moderna COVID-19 vaccine, Elasomeran" (Press release). 24 June 2021. Archived from the original on 27 June 2021. Retrieved 29 June 2021.
  25. ↑ ୨୫.୦ ୨୫.୧ ୨୫.୨ "COVID-19 Vaccine (Moderna) Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Retrieved 28 January 2022.
  26. ↑ ୨୬.୦ ୨୬.୧ "Moderna COVID-19 vaccine". Health Canada. 23 December 2020. Archived from the original on 27 August 2021. Retrieved 28 August 2021.
  27. ↑ Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T (February 2021). "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine". The New England Journal of Medicine. 384 (5): 403–416. doi:10.1056/NEJMoa2035389. PMC 7787219. PMID 33378609. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  28. ↑ "Moderna COVID-19 vaccine - WikiProjectMed". mdwiki.org (in ଇଂରାଜୀ). The New York Times. Januarary 28 2022. Archived from the original on 28 January 2022. Retrieved 28 January 2022. {{cite news}}: Check date values in: |date= (help)
  29. ↑ "COVID-19 Vaccine Tracker: Moderna: mRNA-1273". McGill University. Archived from the original on 2021-12-13. Retrieved 2022-01-03.
  30. ↑ Jr, Berkeley Lovelace (5 August 2020). "Moderna is pricing coronavirus vaccine at $32 to $37 per dose for some customers". CNBC (in ଇଂରାଜୀ). Archived from the original on 13 January 2022. Retrieved 28 January 2022.
  31. ↑ "Fact check: Moderna vaccine funded by government spending, with notable private donation". USA Today. 24 November 2020. Archived from the original on 25 April 2021. Retrieved 25 April 2021.
  32. ↑ Whittacker, Elizabeth; Heath, Paul T. (2021). "27. COVID-19 in children and COVID-19 vaccines". In Vesikari, Timo; Damme, Pierre Van (eds.). Pediatric Vaccines and Vaccinations: A European Textbook (in ଇଂରାଜୀ) (Second ed.). Switzerland: Springer. p. 299. ISBN 978-3-030-77172-0. Archived from the original on 2022-01-29. Retrieved 2022-01-29.
"https://or.wikipedia.org/w/index.php?title=ମୋଡର୍ନା_କୋଭିଡ଼-୧୯_ଟିକା&oldid=487102"ରୁ ଅଣାଯାଇଅଛି